Polycystic ovary syndrome: the new millenium (Q34428353)

2 August 2017

1 reference

title

Polycystic ovary syndrome: the new millenium (English)

1 reference

polycystic ovary syndrome

2 August 2017

1 reference

1 reference

Legro RS

1

1 reference

PubMed ID

11694344

2 August 2017

language of work or name

1 reference

1 November 2001

1 reference

Molecular and Cellular Endocrinology

2 August 2017

1 reference

2 August 2017

184

1 reference

2 August 2017

1-2

1 reference

2 August 2017

87-93

1 reference

Cumulative conception and live birth rates after the treatment of anovulatory infertility: safety and efficacy of ovulation induction in 200 patients.

2 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900640-2

7 January 2021

Native gonadotropin-releasing hormone for triggering follicular maturation in polycystic ovary syndrome patients undergoing human menopausal gonadotropin ovulation induction

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900640-2

7 January 2021

Polycystic ovary syndrome: pathophysiology and outcome with in vitro fertilization.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900640-2

7 January 2021

Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900640-2

7 January 2021

Increased risk of non-insulin dependent diabetes mellitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of the polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900640-2

7 January 2021

The impact of insulin resistance on the outcome of ovulation induction with low-dose follicle stimulating hormone in women with polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900640-2

7 January 2021

A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900640-2

7 January 2021

Surgically induced ovulation in the polycystic ovary syndrome: wedge resection revisited in the age of laparoscopy.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900640-2

7 January 2021

Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900640-2

7 January 2021

Insulin-lowering therapeutic modalities for polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900640-2

7 January 2021

Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900640-2

7 January 2021

Women with polycystic ovary syndrome gain regular menstrual cycles when ageing

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900640-2

7 January 2021

Treatment of anovulatory infertility: the problem of multiple pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900640-2

7 January 2021

The prevalence of polycystic ovaries on ultrasound scanning in a population of randomly selected women.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900640-2

7 January 2021

Polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900640-2

7 January 2021

Prevalence of and etiological factors in polycystic ovarian syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900640-2

7 January 2021

The Impact of Insulin Secretion on the Ovarian Response to Exogenous Gonadotropins in Polycystic Ovary Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900640-2

7 January 2021

Polycystic ovaries and the risk of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900640-2

7 January 2021

Association of the steroid synthesis gene CYP11a with polycystic ovary syndrome and hyperandrogenism

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900640-2

7 January 2021

Metformin-induced resumption of normal menses in 39 of 43 (91%) previously amenorrheic women with the polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900640-2

7 January 2021

CLINICAL AND BIOCHEMICAL FEATURES OF POLYCYSTIC OVARIAN DISEASE.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900640-2

7 January 2021

Carotid atherosclerosis in women with polycystic ovary syndrome: initial results from a case-control study.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900640-2

7 January 2021

Objective assessment of treatment response in hirsutism

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900640-2

7 January 2021

Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900640-2

7 January 2021

Protection against endometrial carcinoma by combination-product oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900640-2

7 January 2021

Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900640-2

7 January 2021

High density lipoprotein cholesterol as a predictor of cardiovascular disease mortality in men and women: the follow-up study of the Lipid Research Clinics Prevalence Study

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900640-2

7 January 2021

Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900640-2

7 January 2021

Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900640-2

7 January 2021

Metformin therapy decreases hyperandrogenism and hyperinsulinemia in women with polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900640-2

7 January 2021

Polycystic ovary syndrome. Phenotype to genotype

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900640-2

7 January 2021

Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900640-2

7 January 2021

Hirsutism in polycystic ovary syndrome: current concepts

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900640-2

7 January 2021

Evidence for the Importance of Peripheral Tissue Events in the Development of Hirsutism in Polycystic Ovary Syndrome*

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900640-2

7 January 2021

Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900640-2

7 January 2021

Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900640-2

7 January 2021

Comparison of spironolactone, flutamide, and finasteride efficacy in the treatment of hirsutism: a randomized, double blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900640-2

7 January 2021

Insulin regulation of human ovarian androgens

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900640-2

7 January 2021

Evidence that an altered prolactin release is consequent to abnormal ovarian activity in polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900640-2

7 January 2021

The natural history of the metabolic syndrome in young women with the polycystic ovary syndrome and the effect of long-term oestrogen-progestagen treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900640-2

7 January 2021

Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900640-2

7 January 2021

Mortality of women with polycystic ovary syndrome at long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900640-2

7 January 2021

Polycystic ovaries--a common finding in normal women

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900640-2

7 January 2021

Banting lecture 1988. Role of insulin resistance in human disease

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900640-2

7 January 2021

Epithelial ovarian cancer risk among women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900640-2

7 January 2021

Increased 5 alpha-reductase activity in idiopathic hirsutism

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900640-2

7 January 2021

Adverse lipid and coronary heart disease risk profiles in young women with polycystic ovary syndrome: results of a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900640-2

7 January 2021

Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900640-2

7 January 2021

Menstrual cyclicity after metformin therapy in polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900640-2

7 January 2021

Endometrial and ovarian cancer and oral contraceptives--findings in a large cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900640-2

7 January 2021

Recency, duration, and progestin content of oral contraceptives in relation to the incidence of endometrial cancer (Washington, USA)

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900640-2

7 January 2021

Hyperfunction of the hypothalamic-pituitary axis in women with polycystic ovarian disease: indirect evidence for partial gonadotroph desensitization.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900640-2

7 January 2021

The use of human gonadotropins for the induction of ovulation in women with polycystic ovarian disease

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900640-2

7 January 2021

Linkage and association of insulin gene VNTR regulatory polymorphism with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900640-2

7 January 2021

Use of oral contraceptives and endometrial cancer risk (Sweden)

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900640-2

7 January 2021

High density lipoprotein cholesterol and mortality. The Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900640-2

7 January 2021

Serum testosterone levels decrease in middle age in women with the polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900640-2

7 January 2021

Comparison of effects of different combined oral-contraceptive formulations on carbohydrate and lipid metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900640-2

7 January 2021

10.1016/S0303-7207(01)00640-2

Identifiers

DOI

1 reference

2 August 2017

1 reference

PubMed ID

11694344